Acute heart failure registry from high-volume university hospital ED: comparing European and US data
Language English Country United States Media print-electronic
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
21641150
DOI
10.1016/j.ajem.2011.03.027
PII: S0735-6757(11)00130-6
Knihovny.cz E-resources
- MeSH
- Acute Disease MeSH
- Hemoglobins analysis MeSH
- Kaplan-Meier Estimate MeSH
- Blood Pressure physiology MeSH
- Humans MeSH
- Hospital Mortality MeSH
- Hospitals, University statistics & numerical data MeSH
- Statistics, Nonparametric MeSH
- Proportional Hazards Models MeSH
- Prospective Studies MeSH
- Registries MeSH
- Aged MeSH
- Heart Failure epidemiology mortality physiopathology MeSH
- Stroke Volume physiology MeSH
- Emergency Service, Hospital statistics & numerical data MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Geographicals
- Europe epidemiology MeSH
- United States epidemiology MeSH
- Names of Substances
- Hemoglobins MeSH
BACKGROUND: Acute heart failure (AHF) is associated with a poor prognosis. OBJECTIVES: The objectives of this study are to describe mechanisms of AHF and to identify the predictors for all-cause mortality by patients admitted for hospitalization by emergency departments (EDs) as well as to compare European and American data. METHODS: We designed a prospective registry of consecutively admitted patients for AHF to a high-volume university hospital ED during a 1-year period (n=202; age, 75±11 years; 51% men; ejection fraction, 38%±15%). RESULTS: The major causes of AHF were coronary artery disease, often with concomitant mitral regurgitation, hypertension, or atrial fibrillation (>90% of cases). At admission, 24.9% of patients had preserved ejection fractions (>50%); and only 7.7% fulfilled the definition of diastolic AHF. The 30-day and long-term mortality (median follow-up, 793 days) were 20.3% and 31.0%, respectively. A low systolic blood pressure (P=.006), reduced ejection fraction (P=.044), and low serum hemoglobin level (P<.01) emerged as the strongest predictors of all-cause mortality. In patients with AHF without acute myocardial infarction (MI) (63.9%), prescription, at discharge, of statins (P<.05) was independently associated with all-cause mortality. CONCLUSIONS: The patient's blood pressure, ejection fraction, and hemoglobin values, at admission, were identified as the strongest predictors of all-cause mortality. In AHF not triggered by acute MI, long-term use of statins may be associated with reduced survival. The prevalence of diastolic AHF is low. The American AHF population had similar baseline characteristics; needed fewer intensive care unit admissions; had a better 30 days of prognosis, lower incidence of MI, and de novo AHF diagnoses. In a similar subgroup, we observed similar incidences of inotropic support and mechanical ventilation. Our results could not be generalized to all patients with AHF admitted to US EDs.
References provided by Crossref.org